Bempedoic Acid Impurity 10, identified by its CAS number 1529323-27-0, is a chemical compound that serves as an impurity associated with the synthesis of bempedoic acid, a medication used to lower cholesterol levels. While specific characteristics of this impurity may not be extensively documented, impurities in pharmaceutical compounds typically exhibit properties such as varying solubility, stability, and reactivity compared to the parent compound. Bempedoic acid itself is a prodrug that is converted in the body to its active form, which inhibits ATP-citrate lyase, thereby reducing cholesterol synthesis. Impurities like Bempedoic Acid Impurity 10 are important to monitor during drug development and manufacturing processes, as they can affect the safety, efficacy, and quality of the final pharmaceutical product. Analytical techniques such as HPLC (High-Performance Liquid Chromatography) and mass spectrometry are commonly employed to identify and quantify such impurities to ensure compliance with regulatory standards. Understanding the characteristics of impurities is crucial for maintaining the integrity of pharmaceutical formulations.

Bempedoic Acid Impurity 10

1529323-27-0: Bempedoic Acid Impurity 10, identified by its CAS number 1529323-27-0, is a chemical compound that serves as an impurity associated with the synthesis of bempedoic acid, a medication used to lower cholesterol levels. While specific characteristics of this impurity may not be extensively documented, impurities in pharmaceutical compounds typically exhibit properties such as varying solubility, stability, and reactivity compared to the parent compound. Bempedoic acid itself is a prodrug that is converted in the body to its active form, which inhibits ATP-citrate lyase, thereby reducing cholesterol synthesis. Impurities like Bempedoic Acid Impurity 10 are important to monitor during drug development and manufacturing processes, as they can affect the safety, efficacy, and quality of the final pharmaceutical product. Analytical techniques such as HPLC (High-Performance Liquid Chromatography) and mass spectrometry are commonly employed to identify and quantify such impurities to ensure compliance with regulatory standards. Understanding the characteristics of impurities is crucial for maintaining the integrity of pharmaceutical formulations.

CAS 1529323-27-0

Bempedoic Acid Impurity 10

Bempedoic Acid Impurity 30

Ref: ST-EA-CP-B42031